XML 67 R53.htm IDEA: XBRL DOCUMENT v3.22.0.1
General and Description of the Business - Additional Information (Details)
$ / shares in Units, $ in Millions
1 Months Ended 12 Months Ended
Feb. 05, 2021
USD ($)
Feb. 05, 2021
USD ($)
Jan. 25, 2021
Sep. 30, 2021
shares
Jan. 31, 2021
USD ($)
$ / shares
shares
Jan. 02, 2022
USD ($)
Country
$ / shares
shares
Jan. 03, 2021
USD ($)
$ / shares
Dec. 29, 2019
USD ($)
$ / shares
Sep. 30, 2022
General And Description Of Business [Line Items]                  
Percentage Of Shares Acquired           38.00%      
Proceeds from Issuance Initial Public Offering           $ 1,426.4 $ 0.0 $ 0.0  
Selling, marketing and administrative expenses           555.0 489.6 515.1  
Cash and cash equivalents           309.7 132.8 72.0  
Accumulated deficit           (1,971.8) (1,917.5)    
Net loss           (54.3) (211.9) (156.9)  
Net Cash Provided by (Used in) Operating Activities           286.6 $ 46.1 $ 143.0  
Long-term Line of Credit           46.3      
Letters of Credit Outstanding, Amount           $ 46.3      
Revolving Credit Facility                  
General And Description Of Business [Line Items]                  
Maximum Percentage Of Committed Amount For First Lien Net Leverage Ratio           30.00%      
Long-term Line of Credit           $ 0.0      
Revolving Credit Facility | Forecast                  
General And Description Of Business [Line Items]                  
Basis Point Step Downs Of First Lien Net Leverage Ratio                 0.50
Dollar Term Loan Facility                  
General And Description Of Business [Line Items]                  
Repayments of Senior Debt           892.7      
2025 Notes                  
General And Description Of Business [Line Items]                  
Repayments of Debt   $ 160.0       160.0      
Redemption premium           11.8      
2028 Notes                  
General And Description Of Business [Line Items]                  
Repayments of Debt $ 270.0         270.0      
Redemption premium $ 19.6         19.6      
Secondary Public Offering                  
General And Description Of Business [Line Items]                  
Selling, marketing and administrative expenses           1.1      
Business Acquisitions [Member]                  
General And Description Of Business [Line Items]                  
Amount receivable on Business Combination agreement Termination by Quidel           $ 207.8      
Minimum                  
General And Description Of Business [Line Items]                  
Number of countries and territories with commercial presence | Country           130      
Share Price | $ / shares           $ 19.06 $ 12.56 $ 11.92  
Maximum                  
General And Description Of Business [Line Items]                  
Share Price | $ / shares           $ 19.97 $ 14.13 $ 12.55  
Maximum | Revolving Credit Facility                  
General And Description Of Business [Line Items]                  
First Lien Net Leverage Ratio           5.5      
Quidel                  
General And Description Of Business [Line Items]                  
Percentage Of Shares Acquired           62.00%      
Quidel | Business Acquisitions [Member]                  
General And Description Of Business [Line Items]                  
Termination Fee           $ 46.9      
Ortho-Clinical Diagnostics Holdings Luxembourg S.à r.l | UK Holdco                  
General And Description Of Business [Line Items]                  
Ownership interest           100.00%      
Ortho-Clinical Diagnostics S.A.                  
General And Description Of Business [Line Items]                  
Stock Issued During Period Shares Other | shares           0.1055      
Issuance of incorporation shares consisting of ordinary shares and preferred redeemable shares, shares | shares           0.1055      
Ortho-Clinical Diagnostics S.A. | UK Holdco                  
General And Description Of Business [Line Items]                  
Ownership interest           100.00%      
Ordinary Shares                  
General And Description Of Business [Line Items]                  
Stock Issued During Period Shares Other | shares           1      
Common Stock, Conversion Basis     1-for-1            
Shares, Issued | shares           87,400,000      
Proceeds from Issuance Initial Public Offering         $ 1,426.4        
Issuance of incorporation shares consisting of ordinary shares and preferred redeemable shares, shares | shares           1      
Ordinary Shares | IPO                  
General And Description Of Business [Line Items]                  
Shares, Issued | shares         87,400,000        
Ordinary Shares | Secondary Public Offering                  
General And Description Of Business [Line Items]                  
Shares, Issued | shares       25,300,000          
Ordinary Shares | Over-Allotment Option                  
General And Description Of Business [Line Items]                  
Stock Issued During Period Shares Other | shares       3,300,000          
Shares, Issued | shares         11,400,000        
Issuance of incorporation shares consisting of ordinary shares and preferred redeemable shares, shares | shares       3,300,000          
Ordinary Shares | Business Acquisitions [Member] | IPO                  
General And Description Of Business [Line Items]                  
Share Price | $ / shares         $ 17.00        
Ordinary Shares | Ortho-Clinical Diagnostics S.A.                  
General And Description Of Business [Line Items]                  
Share price | $ / shares           $ 7.14      
Preferred Redeemable Shares                  
General And Description Of Business [Line Items]                  
Stock Issued During Period Shares Other | shares           50,000      
Issuance of incorporation shares consisting of ordinary shares and preferred redeemable shares, shares | shares           50,000